Title:
NUCLEIC ACID COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2024/023252
Kind Code:
A3
Abstract:
The present invention provides novel nucleic acid compound suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.
Inventors:
MCCARTHY AMY (GB)
CRAGGS GRAHAM (GB)
LONGDEN JAMES (GB)
DE SANTIAGO INES (GB)
BROWN DUNCAN (GB)
MORTAZAVI AHMAD ALI (GB)
MANNELLA VIVIANA (GB)
JAYARAMAN MUTHUSAMY (GB)
DEBACKER ALEXANDRE (GB)
MOGG ADRIAN JAMES (GB)
CRAGGS GRAHAM (GB)
LONGDEN JAMES (GB)
DE SANTIAGO INES (GB)
BROWN DUNCAN (GB)
MORTAZAVI AHMAD ALI (GB)
MANNELLA VIVIANA (GB)
JAYARAMAN MUTHUSAMY (GB)
DEBACKER ALEXANDRE (GB)
MOGG ADRIAN JAMES (GB)
Application Number:
PCT/EP2023/070904
Publication Date:
March 07, 2024
Filing Date:
July 27, 2023
Export Citation:
Assignee:
E THERAPEUTICS PLC (GB)
International Classes:
C12N15/113
Domestic Patent References:
| WO2012177639A2 | 2012-12-27 | |||
| WO2004070062A2 | 2004-08-19 | |||
| WO2023059948A1 | 2023-04-13 |
Other References:
LIN WEN-YI ET AL: "RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A", MOLECULAR THERAPY-NUCLEIC ACIDS, vol. 24, 1 June 2021 (2021-06-01), US, pages 658 - 668, XP055976579, ISSN: 2162-2531, DOI: 10.1016/j.omtn.2021.03.022
Attorney, Agent or Firm:
VOSSIUS & PARTNER PATENTANWÄLTE RECHTSANWÄLTE MBB (DE)
Download PDF:
Previous Patent: DOUBLE STRANDED NUCLEIC ACID COMPOUNDS INHIBITING ZPI
Next Patent: FIRST BLADE SEGMENT FOR A SEGMENTED WIND TURBINE ROTOR BLADE
Next Patent: FIRST BLADE SEGMENT FOR A SEGMENTED WIND TURBINE ROTOR BLADE